Literature DB >> 9690622

Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.

J S Isaacs1, R Hardman, T A Carman, J C Barrett, B E Weissman.   

Abstract

Neuroblastoma (NB) cells in vitro are capable of bidirectional transdifferentiation, resulting in two distinct, yet reversible, phenotypes of neuroblastic (N-type) and nonneuronal (S-type) Schwann-like cells. Our previous studies suggested that the wild-type p53 protein is subject to differential regulation in a subset of neuronal cell types. To further test this hypothesis, we compared p53 function in three matched pairs of N- and S-type cell lines, each pair originating from an individual NB tumor. Our data show that although p53 remains cytoplasmically sequestered in a punctate pattern in N-type cells after DNA damage, the protein is diffusely distributed in the S-type cells and is additionally capable of translocating to the nucleus and mediating a biological response to this damage. Our data, therefore, suggest that the p53 protein may be differentially regulated by a neuronal cellular environment and that the sequestration of p53 in NB may be reversible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690622

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

Authors:  Chinthalapally V Rao; Jagan Mohan R Patlolla; Li Qian; Yuting Zhang; Misty Brewer; Altaf Mohammed; Dhimant Desai; Shantu Amin; Stan Lightfoot; Levy Kopelovich
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53.

Authors:  Jorge Nieva; Byeong-Doo Song; Joseph K Rogel; David Kujawara; Lawrence Altobel; Alicia Izharrudin; Grant E Boldt; Rajesh K Grover; Anita D Wentworth; Paul Wentworth
Journal:  Chem Biol       Date:  2011-07-29

3.  Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins.

Authors:  P J Moos; K Edes; F A Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.

Authors:  D A Tweddle; A J Malcolm; M Cole; A D Pearson; J Lunec
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.

Authors:  Meysam Yousefi; Seyed H Ghaffari; Bahram M Soltani; Shahriar Nafissi; Majid Momeny; Ali Zekri; Mehrdad Behmanesh; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Neurochem Res       Date:  2012-06-21       Impact factor: 3.996

6.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

7.  Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Authors:  Dong Hwan Ho; Hyejung Kim; Jisun Kim; Hyuna Sim; Hyunjun Ahn; Janghwan Kim; Hyemyung Seo; Kwang Chul Chung; Bum-Joon Park; Ilhong Son; Wongi Seol
Journal:  Mol Brain       Date:  2015-09-18       Impact factor: 4.041

Review 8.  Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.

Authors:  Kevin Zhai; Aranka Brockmüller; Peter Kubatka; Mehdi Shakibaei; Dietrich Büsselberg
Journal:  Biomolecules       Date:  2020-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.